NTRR Partner S2O2 Completes Successful Case Study With One of North America's Largest Ambulance Fleets

TAMPA, Fla.--(BUSINESS WIRE)--

Neutra Corp. NTRR announced today that its joint venture partner, Surface to Air Solutions (S2O2), recently completed an exhaustive product case study with one of the largest ambulance fleets in North America.

The successful trial run began this summer, when S2O2 agreed to provide its cutting-edge anti-microbial coatings for some of the most critical vehicles on the road, protecting patients and first responders from the risk of infection during ambulance rides around the country. Last year, S2O2 acquired Zero-Blast, a Texas-based company that specializes in advanced, anti-microbial coatings for germ-infested environments, including hospitals and locker rooms.

"The results exceeded our expectations," said NTRR CEO Chris Brown. "The Zero-Blast product performed fantastically, continuously keeping germ counts extremely low with a single application and allowing emergency personnel to focus on taking care of patients."

The company's safe, non-toxic treatment needs only to be applied four times a year in order to provide 24/7 protection from potentially deadly viruses and infections. It's a top-notch solution that NTRR and S2O2 have teamed up to market and promote to ambulance fleets and first responders across North America.

"Unlike other disinfectants that don't last, Zero-Blast's products continue working for up to 90 days on all surfaces, providing long-lasting protection from disease and infection," Brown said. "It's perfect for ambulances and other emergency vehicles, and we're already in talks with other emergency service providers about making Zero-Blast standard equipment in their fleets."

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing wellness sector alongside Herbalife Ltd. (HLF), Vitamin Shoppe (VSI), Nutraceutical International Corp. (NUTR) and Schiff Nutrition International Inc. WNI.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals GWPRF, INSYS Therapeutics, Inc. INSY and ENDEXX Corp. EDXC, delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150922005536/en/